PTGES3L
gene geneOn this page
Summary
PTGES3L (prostaglandin E synthase 3 like, HGNC:43943) is a protein-coding gene on chromosome 17q21.31, encoding Putative protein PTGES3L (E9PB15).
Predicted to enable Hsp90 protein binding activity and protein-folding chaperone binding activity. Predicted to be involved in chaperone-mediated protein complex assembly and protein folding. Predicted to be located in cytoplasm. Predicted to be active in cytosol and nucleus.
Source: NCBI Gene 100885848 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 3 total
- MANE Select transcript:
NM_001261430
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:43943 |
| Approved symbol | PTGES3L |
| Name | prostaglandin E synthase 3 like |
| Location | 17q21.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000267060 |
| Ensembl biotype | protein_coding |
| Entrez | 100885848 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 13 protein_coding, 2 retained_intron
ENST00000409446, ENST00000424284, ENST00000451885, ENST00000462157, ENST00000464183, ENST00000591916, ENST00000872822, ENST00000872823, ENST00000916932, ENST00000945107, ENST00000945108, ENST00000945109, ENST00000945110, ENST00000945111, ENST00000945112
RefSeq mRNA: 3 — MANE Select: NM_001261430
NM_001142653, NM_001142654, NM_001261430
CCDS: CCDS45692, CCDS45693, CCDS92328
Canonical transcript exons
ENST00000591916 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002750923 | 42980046 | 42980080 |
| ENSE00002956195 | 42968103 | 42969186 |
| ENSE00003511040 | 42979550 | 42979663 |
| ENSE00003578157 | 42970289 | 42970342 |
| ENSE00003594880 | 42979170 | 42979268 |
| ENSE00003639473 | 42971607 | 42971696 |
| ENSE00003650476 | 42979378 | 42979444 |
Expression profiles
Bgee: expression breadth ubiquitous, 168 present calls, max score 94.69.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0622 / max 5.7102, expressed in 31 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 166195 | 0.6914 | 302 |
| 166197 | 0.0622 | 31 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 94.69 | gold quality |
| gastrocnemius | UBERON:0001388 | 94.23 | gold quality |
| muscle of leg | UBERON:0001383 | 92.69 | gold quality |
| tibialis anterior | UBERON:0001385 | 90.57 | gold quality |
| right atrium auricular region | UBERON:0006631 | 89.54 | gold quality |
| heart left ventricle | UBERON:0002084 | 88.95 | gold quality |
| cardiac ventricle | UBERON:0002082 | 88.17 | gold quality |
| cardiac atrium | UBERON:0002081 | 87.58 | gold quality |
| apex of heart | UBERON:0002098 | 86.86 | gold quality |
| heart | UBERON:0000948 | 85.13 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 84.75 | gold quality |
| quadriceps femoris | UBERON:0001377 | 83.26 | silver quality |
| deltoid | UBERON:0001476 | 83.03 | silver quality |
| muscle tissue | UBERON:0002385 | 82.62 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 82.60 | gold quality |
| vastus lateralis | UBERON:0001379 | 81.68 | silver quality |
| biceps brachii | UBERON:0001507 | 80.76 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.32 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 79.55 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 79.03 | gold quality |
| lower esophagus | UBERON:0013473 | 78.99 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 78.85 | gold quality |
| heart right ventricle | UBERON:0002080 | 78.53 | silver quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 77.59 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 77.24 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 76.20 | gold quality |
| popliteal artery | UBERON:0002250 | 74.08 | gold quality |
| tibial artery | UBERON:0007610 | 74.05 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.11 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 72.52 | silver quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-111727 | yes | 138.72 |
| E-MTAB-5061 | no | 3.47 |
| E-ANND-3 | no | 2.71 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
71 targeting PTGES3L, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-518D-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-518E-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-518F-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-519A-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519B-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-519C-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-520C-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-522-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-523-5P | 100.00 | 67.66 | 954 |
| HSA-MIR-526A-5P | 100.00 | 67.51 | 979 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-520G-5P | 99.99 | 66.76 | 658 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-3119 | 99.92 | 71.34 | 2390 |
| HSA-MIR-6780A-5P | 99.88 | 66.69 | 2776 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-4659A-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-4659B-3P | 99.80 | 72.62 | 4248 |
| HSA-MIR-1273H-5P | 99.77 | 66.32 | 2471 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
| HSA-MIR-30B-3P | 99.70 | 65.76 | 2325 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | ptges3l | ENSDARG00000079462 |
| mus_musculus | Ptges3l | ENSMUSG00000097487 |
| rattus_norvegicus | Ptges3l | ENSRNOG00000050347 |
| drosophila_melanogaster | p23 | FBGN0037728 |
| caenorhabditis_elegans | WBGENE00022599 |
Paralogs (1): PTGES3 (ENSG00000110958)
Protein
Protein identifiers
Putative protein PTGES3L — E9PB15 (reviewed: E9PB15)
Alternative names: Prostaglandin E synthase 3-like
All UniProt accessions (5): A0A7N4I3A5, C9JG77, E9PB15, H7C1Q7, K7N7A2
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the p23/wos2 family.
Isoforms (5)
| UniProt ID | Names | Canonical? |
|---|---|---|
| E9PB15-1 | 1 | yes |
| Q9BTE6-2 | 2 | |
| Q9BTE6-3 | 3 | |
| E9PB15-2 | 4 | |
| E9PB15-3 | 5 |
RefSeq proteins (3): NP_001136125, NP_001136126, NP_001248359* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR007052 | CS_dom | Domain |
| IPR008978 | HSP20-like_chaperone | Homologous_superfamily |
| IPR045250 | p23-like | Family |
UniProt features (7 total): splice variant 3, chain 1, domain 1, region of interest 1, compositionally biased region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E9PB15-F1 | 74.08 | 0.29 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 40 (showing top):
GOBP_CHAPERONE_MEDIATED_PROTEIN_COMPLEX_ASSEMBLY, GOBP_PROTEIN_MATURATION, GOBP_PROTEIN_FOLDING, GOMF_HEAT_SHOCK_PROTEIN_BINDING, GOMF_HSP90_PROTEIN_BINDING, GOMF_PROTEIN_FOLDING_CHAPERONE_BINDING, FOXN3_TARGET_GENES, NME2_TARGET_GENES, RBM34_TARGET_GENES, ZBTB12_TARGET_GENES, ZNF513_TARGET_GENES, ZNF664_TARGET_GENES, MIR616_5P, MIR371B_5P, MIR373_5P
GO Biological Process (6): protein folding (GO:0006457), chaperone-mediated protein complex assembly (GO:0051131), prostaglandin biosynthetic process (GO:0001516), fatty acid metabolic process (GO:0006631), fatty acid biosynthetic process (GO:0006633), prostaglandin metabolic process (GO:0006693)
GO Molecular Function (3): protein-folding chaperone binding (GO:0051087), Hsp90 protein binding (GO:0051879), isomerase activity (GO:0016853)
GO Cellular Component (3): nucleus (GO:0005634), cytosol (GO:0005829), cytoplasm (GO:0005737)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| cellular process | 1 |
| protein maturation | 1 |
| protein-containing complex assembly | 1 |
| prostaglandin metabolic process | 1 |
| prostanoid biosynthetic process | 1 |
| lipid metabolic process | 1 |
| monocarboxylic acid metabolic process | 1 |
| fatty acid metabolic process | 1 |
| lipid biosynthetic process | 1 |
| monocarboxylic acid biosynthetic process | 1 |
| prostanoid metabolic process | 1 |
| protein binding | 1 |
| heat shock protein binding | 1 |
| catalytic activity | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| intracellular anatomical structure | 1 |
Protein interactions and networks
STRING
653 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| PTGES3L | RUNDC1 | Q96C34 | 442 |
| PTGES3L | SRFBP1 | Q8NEF9 | 399 |
| PTGES3L | RSL24D1 | Q9UHA3 | 395 |
| PTGES3L | SUGT1 | Q9Y2Z0 | 388 |
| PTGES3L | NSA2 | O95478 | 382 |
| PTGES3L | EFCAB11 | Q9BUY7 | 360 |
| PTGES3L | LY6G5C | Q5SRR4 | 357 |
| PTGES3L | PTGES2 | Q9H7Z7 | 326 |
| PTGES3L | AHSA1 | O95433 | 323 |
| PTGES3L | NOP53 | Q9NZM5 | 318 |
| PTGES3L | PLA2G12B | Q9BX93 | 311 |
| PTGES3L | CNIH3 | Q8TBE1 | 310 |
| PTGES3L | GMCL1 | Q96IK5 | 309 |
| PTGES3L | OXSR1 | O95747 | 300 |
| PTGES3L | PRXL2B | Q8TBF2 | 300 |
IntAct
0 interactions, top by confidence:
BioGRID (2): PTGES3L (Affinity Capture-MS), PTGES3L (Affinity Capture-MS)
ESM2 similar proteins: A2WXR5, A2Y0Q2, A2Y4R8, A9LMC0, B4GDK5, B8ADZ3, B8AMA8, B8B8I3, B8BJV8, E9PB15, F4I2J8, O54917, O60291, O75461, O75896, O81488, P0DOC8, P24051, P58268, P58269, Q08DY6, Q292G3, Q2R837, Q3T0B7, Q40359, Q5XEM9, Q60DW3, Q6IV56, Q6PI47, Q6XL73, Q6Z7F4, Q6ZWY3, Q717R8, Q71UM5, Q75IR6, Q7F2Z1, Q7LKZ5, Q84TV4, Q8H383, Q8LA16
Diamond homologs: E9PB15, G1TGF1, P83868, Q15185, Q3ZBF7, Q5NVM4, Q6PWL5, Q9D9A7, Q9R0Q7, P28707, Q11118, Q23280, Q90955, Q9FR62, Q5ZM57, Q7SY06
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
3 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1139 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:42970283:ACTT:A | donor_loss | 1.0000 |
| 17:42970284:CTT:C | donor_loss | 1.0000 |
| 17:42970285:TTA:T | donor_loss | 1.0000 |
| 17:42970286:TACA:T | donor_loss | 1.0000 |
| 17:42970287:A:AC | donor_gain | 1.0000 |
| 17:42970287:A:C | donor_loss | 1.0000 |
| 17:42970287:ACAT:A | donor_gain | 1.0000 |
| 17:42970287:ACATC:A | donor_gain | 1.0000 |
| 17:42970288:C:CA | donor_gain | 1.0000 |
| 17:42970288:CA:C | donor_gain | 1.0000 |
| 17:42970288:CAT:C | donor_gain | 1.0000 |
| 17:42970288:CATC:C | donor_gain | 1.0000 |
| 17:42970288:CATCC:C | donor_gain | 1.0000 |
| 17:42971601:TCTCA:T | donor_loss | 1.0000 |
| 17:42971602:CTCA:C | donor_loss | 1.0000 |
| 17:42971603:TCAC:T | donor_loss | 1.0000 |
| 17:42971604:CACC:C | donor_loss | 1.0000 |
| 17:42971605:ACC:A | donor_loss | 1.0000 |
| 17:42971606:CCT:C | donor_gain | 1.0000 |
| 17:42971693:CTGG:C | acceptor_gain | 1.0000 |
| 17:42971697:C:CC | acceptor_gain | 1.0000 |
| 17:42970283:A:AC | donor_gain | 0.9900 |
| 17:42970284:C:CC | donor_gain | 0.9900 |
| 17:42970290:T:TA | donor_gain | 0.9900 |
| 17:42970341:AGCTA:A | acceptor_loss | 0.9900 |
| 17:42970342:GCTAG:G | acceptor_loss | 0.9900 |
| 17:42970343:C:CA | acceptor_loss | 0.9900 |
| 17:42970343:C:CC | acceptor_gain | 0.9900 |
| 17:42971694:TGG:T | acceptor_gain | 0.9900 |
| 17:42971695:GG:G | acceptor_gain | 0.9900 |
AlphaMissense
1059 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000486057 (17:42969096 G>A,C), RS1000800008 (17:42978547 G>C), RS1000912538 (17:42969350 T>G), RS1001207723 (17:42974655 C>A,T), RS1001344922 (17:42974240 G>C), RS1001570091 (17:42974079 C>T), RS1001762427 (17:42981583 C>T), RS1002173208 (17:42967735 G>A), RS1002235083 (17:42972895 G>A), RS1002315650 (17:42971127 G>A), RS1002349528 (17:42972653 G>A), RS1002470277 (17:42980203 T>C,G), RS1002938011 (17:42981733 C>A,T), RS1002975150 (17:42975770 G>A,C), RS1003015025 (17:42981975 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| beta-lapachone | decreases expression, increases expression | 1 |
| abrine | increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Smoke | increases expression | 1 |
| Triclosan | decreases expression | 1 |
| S-Nitrosoglutathione | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.